help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huber, S. A.
Right arrow Articles by Lodge, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber, S. A.
Right arrow Articles by Lodge, P. A.

American Journal of Pathology, Vol 122, 284-291, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice

SA Huber and PA Lodge

DBA/2 and Balb/c mice, both H-2d, develop myocardial inflammation and necrosis when infected with a heart-adapted strain of coxsackievirus Group B, Type 3. Similar inoculation of C57Bl/6 (H-2b) animals results in minimal myocarditis despite equivalent heart virus titers in the three stains. Thus, the host's genetic constitution influences the pathogenesis of the infection. Anti-mouse thymocyte serum and monoclonal Iad antibody effectively prevent myocarditis induction in DBA/2 and Balb/c mice, which demonstrates the importance of the immune system in this disease. Cytolytic T lymphocytes lysing virus-infected and uninfected myocytes and heart-reactive autoantibodies occur in both myocarditis-susceptible strains. Cellular immunity causes the myocardial injury in Balb/c mice. Complement depletion of Balb/c mice using cobra venom factor fails to alter the disease. Similar treatment of DBA/2 animals abrogates inflammation and necrosis, which suggests that heart-reactive antibodies in this strain are primarily responsible for initiating myocardial damage.


This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Fairweather, S. Frisancho-Kiss, D. B. Njoku, J. F. Nyland, Z. Kaya, S. A. Yusung, S. E. Davis, J. A. Frisancho, M. A. Barrett, and N. R. Rose
Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1beta, and Immune Complex Deposition in the Heart
J. Immunol., March 15, 2006; 176(6): 3516 - 3524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. W. Cunningham
Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis
Am. J. Pathol., July 1, 2001; 159(1): 5 - 12.
[Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. W. Cunningham
Pathogenesis of Group A Streptococcal Infections
Clin. Microbiol. Rev., July 1, 2000; 13(3): 470 - 511.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Baboonian and T. Treasure
Meta-analysis of the association of enteroviruses with human heart disease
Heart, December 1, 1997; 78(6): 539 - 543.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.